S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

ELTX Elicio Therapeutics Inc

8.09

-0.72 (-8.17%)

After Hours

Last Updated: 08:38:19

Delayed by 15 minutes

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Elicio Therapeutics (NASDAQ:ELTX)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Elicio Therapeutics Charts.

Elicio Therapeutics (NASDAQ:ELTX)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Elicio Therapeutics Charts.

Elicio Therapeutics Inc News

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 5 February 2025 (6 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 5 February 2025 (6 days ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 31 January 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Friday 31 January 2025 (2 weeks ago) • Edgar (US Regulatory)

Elicio Therapeutics Announces $10.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Friday 31 January 2025 (2 weeks ago) • GlobeNewswire Inc.

Form 8-K - Current report
Friday 24 January 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 22 January 2025 (3 weeks ago) • Edgar (US Regulatory)

Elicio Therapeutics Reaches Alignment with FDA on ELI-002 Registrational Strategy
Wednesday 22 January 2025 (3 weeks ago) • GlobeNewswire Inc.

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Wednesday 8 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 19 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 12 December 2024 (2 months ago) • Edgar (US Regulatory)

Elicio Therapeutics Presents Updated Results from ELI-002 Phase 1 AMPLIFY-201 Study at ESMO Immuno-Oncology Congress 2024
Thursday 12 December 2024 (2 months ago) • GlobeNewswire Inc.

More Elicio Therapeutics Inc News Articles

BNP Paribas Issuance

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions